PHIO
Price:
$1.07
Market Cap:
$12.43M
Phio Pharmaceuticals Corp. is a U.S.-based company dedicated to creating immune-system-focused cancer treatments. Their proprietary INTASYL therapeutic platform aims to influence both tumor and immune cells through the precise regulation of immune system genes. The company's pipeline includes several key candidates for adoptive cell transfer (ACT): PH-762 works by diminishing the expression of the PD-1 checkpoint protein, thereby empowering immune cells to identify and eliminate cancerous cells; PH-894, another candidate, silences BRD4, an epigenetic protein crucial for intracellular gene expression regulation; and PH-804 is designed to target TIGIT, a suppressive immune receptor and checkpo...[Read more]
Industry
Biotechnology
IPO Date
2012-05-10
Stock Exchange
NASDAQ
Ticker
PHIO
According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is -4600542.00. This represents a change of 120.63% compared to the average of -2085210.06 of the last 4 quarters.
The mean historical Enterprise Value of Phio Pharmaceuticals Corp. over the last ten years is -5813220.15. The current -4600542.00 Enterprise Value has changed 7.81% with respect to the historical average. Over the past ten years (40 quarters), PHIO's Enterprise Value was at its highest in in the June 2016 quarter at 11.83M. The Enterprise Value was at its lowest in in the December 2021 quarter at -10241048.00.
Average
-5813220.15
Median
-6708445.69
Minimum
-14747782.15
Maximum
8.95M
Discovering the peaks and valleys of Phio Pharmaceuticals Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 758.60%
Maximum Annual Enterprise Value = 8.95M
Minimum Annual Increase = -240.30%
Minimum Annual Enterprise Value = -14747782.15
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | -14747782.15 | 271.99% |
| 2024 | -3964561.20 | -42.33% |
| 2023 | -6874960.00 | 5.09% |
| 2022 | -6541931.38 | -40.22% |
| 2021 | -10944128.00 | 758.60% |
| 2020 | -1274655.36 | -38.91% |
| 2019 | -2086509.82 | -83.39% |
| 2018 | -12559619.32 | -240.30% |
| 2017 | 8.95M | -210.65% |
| 2016 | -8090026.35 | -140.82% |
The current Enterprise Value of Phio Pharmaceuticals Corp. (PHIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8529101.12
5-year avg
-8614672.55
10-year avg
-5813220.15
Phio Pharmaceuticals Corp.’s Enterprise Value is greater than TransCode Therapeutics, Inc. (-7770350.00), less than Kiora Pharmaceuticals, Inc. (719.67K), greater than IN8bio, Inc. (-12958522.00), less than BioCardia, Inc. (4.56M), greater than Aprea Therapeutics, Inc. (-42010310.00), less than Marker Therapeutics, Inc. (-14642.00), less than Galecto, Inc. (747.52M), less than Creative Medical Technology Holdings, Inc. (-123148.00), greater than Acurx Pharmaceuticals, Inc. (-6766398.00), less than Aptevo Therapeutics Inc. (8.24M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| -7770350.00 | $5.07M | |
| 719.67K | $11.30M | |
| -12958522.00 | $6.63M | |
| 4.56M | $5.10M | |
| -42010310.00 | $4.46M | |
| -14642.00 | $14.90M | |
| 747.52M | $34.47M | |
| -123148.00 | $5.60M | |
| -6766398.00 | $2.49M | |
| 8.24M | $10.45M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Phio Pharmaceuticals Corp.'s Enterprise Value?
What is the highest Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?
What is the 3-year average Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?
What is the 5-year average Enterprise Value for Phio Pharmaceuticals Corp. (PHIO)?
How does the current Enterprise Value for Phio Pharmaceuticals Corp. (PHIO) compare to its historical average?